文献速递关节外科

术中外科医生实施的收肌管阻滞是初次全膝关节置换术中术前麻醉医生实施收肌管阻滞的安全替代方案

Intraoperative Surgeon-Administered Adductor Canal Block Is a Safe Alternative to Preoperative Anesthesiologist-Administered Adductor Canal Block in Primary Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2024-04-09

该回顾性队列研究纳入2019年1月1日至2022年12月31日单中心因初次全膝关节置换术接受低位或高位收肌管阻滞的2620例患者,比较疼痛控制、吗啡消耗量、首次物理治疗步态距离、住院时长及并发症。低位组术后24小时内疼痛评分较高、6小时吗啡毫克当量较高,但无临床意义;12小时和24小时疼痛评分及吗啡用量无差异,30天并发症无差异。作者认为低位收肌管阻滞是有效、安全且经济的替代方案。

要点

  • 低位收肌管阻滞组术后24小时内疼痛评分较高、6小时吗啡毫克当量较高,但作者认为无临床意义。
  • 两组12小时和24小时疼痛评分及吗啡毫克当量无差异,30天并发症无差异。
  • 低位收肌管阻滞是有效、安全且经济的替代方案,不增加手术时间或并发症率。

核心结论

  • 低位收肌管阻滞提供有效镇痛和相当的早期恢复,不增加手术时间或并发症率。
  • 低位收肌管阻滞是高位收肌管阻滞的有效、安全且经济的替代方案。

研究设计与样本

  • 回顾性队列研究,证据等级为治疗性研究III级。
  • 单中心2019年1月1日至2022年12月31日期间接受初次全膝关节置换术并接受低位或高位收肌管阻滞的2620例患者。
  • 低位收肌管阻滞组1248例,高位收肌管阻滞组1372例,两组人口学特征和手术时间相似。

主要发现

  • 低位收肌管阻滞组术后24小时内疼痛评分较高(5.05 vs 4.86,P < .001),作者认为无临床意义。
  • 低位收肌管阻滞组6小时吗啡毫克当量较高(11.49 vs 8.99,P < .001),作者认为无临床意义。
  • 两组12小时疼痛评分(20.81 vs 22.07)和24小时疼痛评分(44.67 vs 48.78)无差异。
  • 低位收肌管阻滞组首次物理治疗步态距离更长(188.5 vs 165.1英尺,P < .001),住院时长更短(0.88 vs 1.46天,P < .01),但作者认为无临床意义。
  • 两组30天并发症(30天再入院和30天急诊就诊)无差异。

临床怎么用

  • 作者认为低位收肌管阻滞是有效、安全且经济的替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The shift toward outpatient total knee arthroplasties (TKAs) has led to a demand for effective perioperative pain control methods. A surgeon-performed "low" adductor canal block ("low-ACB") technique, involving an intraoperative ACB, is gaining popularity due to its efficiency and early pain control potential. This study examined the transition from traditional preoperative anesthesiologist-performed ultrasound-guided adductor canal blocks ("high-ACB") to low-ACB, evaluating pain control, morphine consumption, first physical therapy visit gait distance, hospital length-of-stay, and complications. METHODS: There were 2,620 patients at a single institution who underwent a primary total knee arthroplasty between January 1, 2019, and December 31, 2022, and received either a low-ACB or high-ACB. Cohorts included 1,248 patients and 1,372 patients in the low-ACB and high-ACB groups, respectively. Demographics and operative times were similar. Patient characteristics and outcomes such as morphine milligram equivalents (MMEs), Visual Analog Scale pain scores, gait distance (feet), length of stay (days), and postoperative complications (30-day readmission and 30-day emergency department visit) were collected. RESULTS: The low-ACB cohort had higher pain scores over the first 24 hours (5.05 versus 4.86, P < .001) and higher MME at 6 hours (11.49 versus 8.99, P < .001), although this was not clinically significant. There was no difference in pain scores or MME at 12 or 24 hours (20.81 versus 22.07 and 44.67 versus 48.78, respectively). The low-ACB cohort showed longer gait distance at the first physical therapy visit (188.5 versus 165.1 feet, P < .001) and a shorter length of stay (0.88 versus 1.46 days, P < .01), but these were not clinically significant. There were no differences in 30-day complications. CONCLUSIONS: The low-ACB offers effective pain relief and comparable early recovery without increasing operative time or the complication rate. Low-ACB is an effective, safe, and economical alternative to high-ACB. LEVEL OF EVIDENCE: Therapeutic study, Level III (retrospective cohort study).

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Samuel LT, Pekas DR, Mahoney WA, et al. Intraoperative Surgeon-Administered Adductor Canal Block Is a Safe Alternative to Preoperative Anesthesiologist-Administered Adductor Canal Block in Primary Total Knee Arthroplasty. J Arthroplasty. 2024. PMID: 38599532. doi:10.1016/j.arth.2024.03.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。